Helixgate https://validator.w3.org/feed/docs/rss2.html Congressional Democrats try to force a vote to end Medicare AI prior authorization pilot HELIX AI Model Accurately Predicts RNA Splicing, Unlocks Precision Medicine Live: Senate committee questions NIH director on 2027 budget STAT+: Pioneering trial for treating genetic disease before birth nears reality BMS eyes new campus in Texas; Novartis looks to evict tenant at Slovenian campus Lilly’s triple agonist shows bariatric surgery–like weight loss results How Florida hospitals won big in Medicaid funds (just in time) Vaxart seeks shareholder support as battle over stock split brews Lilly, BMS, Incyte strike deals to keep biopharma’s AI integration rolling Lilly’s triple agonist still leads among late-stage obesity assets STAT+: Lilly’s ‘triple-G’ drug leads to bariatric-surgery levels of weight loss in trial Smile Please: Wisconsin Welcomes FUJIFILM Cellular Dynamics New Headquarters Inside Germany’s biotech capital infrastructure and innovation engine Are ‘AI co-scientist’ tools actually useful for scientists? Biopharma professionals increasingly accept underemployment Real-time volumetric imaging of cells and molecules in deep tissues with Takoyaki ultrasound I&I biotech cAMPfield attracts top-tier investors in $180M Series A The next big pharma company will come from China Opinion: STAT+: Dark times ahead at the FDA Lilly and Engage Bio tie the knot with $202M acquisition Opinion: I saw Ebola as both doctor and patient. I wish people cared more about the Africans I worked alongside STAT+: Kennedy fires two leaders on preventive services task force Standardizing Cell Therapy Production With Technology Facelift University of Dundee leads effort to tackle ‘cruel’ disease  After raising $800M, Parabilis seeks an IPO to pursue ‘undruggable’ targets Bristol Myers deepens AI investment with Anthropic deal FDA sends warning letter after Chinese supplier breaks GLP-1 import restrictions Pfizer’s next-gen pneumonia shot beats Prevnar 20; Relay targets $175M STAT+: Kennedy names interim surgeon general amid vacancies atop health department Pazdur declines to announce candidacy for vacated FDA commissioner role Fetal gene therapy’s progress calls into question the taboo on embryo editing Moderna’s stock rides hantavirus fears as spotlight returns to infectious disease platform GHO Capital, CBC Group plan to merge, forming $21B healthcare investment firm There’s a leadership vacuum at NIH, too Beam one-ups Wave as both show promise of editing for AATD Beam one-ups Wave as both show promise of genetic editing for AATD AbbVie’s new immunology standard-bearer Skyrizi kneels to UCB’s Bimzelx in psoriatic arthritis After Rubio’s critique, WHO defends work on Ebola response FDA’s absent leaders, the millions pharma CEOs make, and pancreatic cancer’s momentum Parabilis reveals IPO plans the day after Regeneron deal as listings heat up STAT+: Senate Democrats propose adding long-term care benefit to Medicare NIH behind in filling top roles, with 15 of 27 institutes led by acting directors Daiichi emerges from bruising 2 years with vision for cracking cancer’s big leagues J&J’s Duato makes 358 times his median employee; Vertex CEO makes just 80 times Incyte signs AI deals with Genesis Molecular AI, Edison Scientific Regeneron, Parabilis Ink Up-to-$2.3B Antibody-Peptide Conjugate Collaboration STAT+: 23andMe offers to connect users’ DNA data with medical records Repetitive temperature cycles with DMSO sustain RNA replicating liposome compartments via fusion mediated content exchange Novel antivenoms bite back Home